A Study to Evaluate the Safety, Tolerability and Efficacy of XEN1101 in Major Depressive Disorder
Trial details
- Registry ID
- NCT05376150
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Evaluate the Safety, Tolerability and Efficacy of XEN1101 in Major Depressive DisorderNCT05376150 | XENE | Phase 2 | Completed | 2023-09-18Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |